title: Memory T-cell response to rotavirus detected with a gamma interferon enzyme-linked immunospot assay.
abstract: Measurements of serum-neutralizing antibody and anti-rotavirus immunoglobulin A (IgA) are the current standard for assessing immune responses following rotavirus vaccination. However, there is ongoing debate as to whether antibody titers correlate with protection against rotavirus gastroenteritis. Children recovering from rotavirus gastroenteritis have increased gamma interferon release from cultured peripheral blood mononuclear cells (PBMCs), suggesting that cell-mediated immunity (CMI) may play a role in viral clearance and protection from subsequent gastroenteritis. We have developed a gamma interferon enzyme-linked immunospot (ELISPOT) assay for evaluation of CMI responses to rotavirus using frozen PBMCs obtained from healthy adults. Responses to three different rotavirus antigen types were analyzed-a peptide pool based on the human VP6 sequence; reassortant human:bovine vaccine strains; and cell culture-adapted (CCA) human G1, G2, G3, G4, and bovine (WC3) G6 strains. The reassortant strains consist of a bovine WC3 genome background expressing the human rotavirus surface proteins VP7 (G1, G2, G3, or G4) or VP4 (P1). Responses to titrations of the peptide pool as well as CCA and reassortant strains were assessed. Gamma interferon ELISPOT responses were similar for CCA and reassortant strains, whether live or UV inactivated, and when tested either individually or pooled. For most subjects, responses to the VP6 peptide pool positively correlated with responses to CCA and reassortant strains. Cell depletion studies indicate the memory responses detected with these frozen adult PBMCs were primarily due to the CD4+ T-cell population. This gamma interferon ELISPOT assay provides a new tool to apply in clinical studies for the characterization of natural or vaccine-induced CMI to rotavirus.
authors.affiliation: Merck & Co., Inc., WP26B-1144A, 770 Sumneytown Pike, West Point, PA 19486, USA. robin_kaufhold@merck.com
authors.forename: Robin M
authors.initials: RM
authors.lastname: Kaufhold
authors.forename: Jodie A
authors.initials: JA
authors.lastname: Field
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Caulfield
authors.forename: Su
authors.initials: S
authors.lastname: Wang
authors.forename: Heather
authors.initials: H
authors.lastname: Joseph
authors.forename: Melissa A
authors.initials: MA
authors.lastname: Wooters
authors.forename: Tina
authors.initials: T
authors.lastname: Green
authors.forename: H Fred
authors.initials: HF
authors.lastname: Clark
authors.forename: David
authors.initials: D
authors.lastname: Krah
authors.forename: Jeffrey G
authors.initials: JG
authors.lastname: Smith
mesh_terms: D000328:Adult; D000368:Aged; D000956:Antigens, Viral / Q000276:immunology; D002478:Cells, Cultured; D006801:Humans; D007111:Immunity, Cellular; D007124:Immunoenzyme Techniques / Q000379:methods*; D007156:Immunologic Memory; D007371:Interferon-gamma / Q000096:biosynthesis; D007963:Leukocytes, Mononuclear; D008875:Middle Aged; D012401:Rotavirus / Q000276:immunology*; D012400:Rotavirus Infections / Q000276:immunology*; D012680:Sensitivity and Specificity; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000956:Antigens, Viral; D007371:Interferon-gamma